Atossa Therapeutics, Inc.

Contributing Author

Recent Articles by Atossa Therapeutics, Inc.

Sep-17	Atossa Therapeutics Appoints CORE IR for Investor Relations, Shareholder Communications and Public Relations Services ATOS GlobeNewswire
Apr-30	Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,281,056, Including 58 Claims Covering Various Formulations for its (Z)-endoxifen Portfolio ATOS GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information